|
Competitor Analysis: Alzheimer’s Disease AntibodiesPublished by: La Merie S.L. Published: Jul. 6, 2008 - 5 Pages Table of Contents
AbstractThe Competitive Intelligence Report Alzheimer's Disease Antibodies as of July 2008 provides a competitor analysis in the development pipeline of novel antibodies for passive immunotherapy of Alzheimer’s disease including those targeting amyloid-beta (beta-amyloid). Among the companies active in the field of new antibodies for passive immunotherapy of Alzheimer’s disease Wyeth, Elan, Pfizer, Roche and many others.The report includes a compilation of current active projects in research and development of novelantibodies for passive immunotherapy of Alzheimer’s disease. Competitor projects are listed in a tabular format providing Information on:
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||